Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
23
SINT Quote, Financials, Valuation and Earnings
Last price:
$3.55
Seasonality move
:
-9.45%
Day range:
$3.49 - $3.62
52-week range:
$1.71 - $7.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.00x
P/B ratio:
3.35x
Volume:
12.5K
Avg. volume:
79.3K
1-year change:
-4.32%
Market cap:
$13.6M
Revenue:
$2.9M
EPS (TTM):
-$6.93
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SINT
SINTX Technologies, Inc.
|
$200K | -$0.55 | -44.65% | -56.43% | $12.25 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -54.48% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
NVNO
enVVeno Medical Corp.
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
XAIR
Beyond Air, Inc.
|
$2.5M | -$0.26 | 243.81% | -8.29% | $10.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SINT
SINTX Technologies, Inc.
|
$3.54 | $12.25 | $13.6M | -- | $0.00 | 0% | 6.00x |
|
IVF
INVO Fertility, Inc.
|
$0.87 | -- | $13.2M | -- | $0.00 | 0% | 0.02x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.77 | $2.23 | $38.6M | -- | $0.00 | 0% | 2.54x |
|
NTRB
Nutriband, Inc.
|
$4.74 | $15.00 | $57.6M | -- | $0.00 | 0% | 23.65x |
|
NVNO
enVVeno Medical Corp.
|
$0.35 | $12.50 | $7.2M | -- | $0.00 | 0% | 473.07x |
|
XAIR
Beyond Air, Inc.
|
$0.82 | $10.33 | $3.8M | -- | $0.00 | 0% | 3.66x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SINT
SINTX Technologies, Inc.
|
45.47% | 1.079 | 22.94% | 1.47x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 2.039 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.796 | 0.32% | 7.07x |
|
NVNO
enVVeno Medical Corp.
|
2.62% | 2.197 | 4.32% | 12.90x |
|
XAIR
Beyond Air, Inc.
|
48.09% | 1.510 | 106.48% | 2.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
NVNO
enVVeno Medical Corp.
|
-$120K | -$4.9M | -56.26% | -57.7% | -- | -$4.4M |
|
XAIR
Beyond Air, Inc.
|
-$298K | -$7.7M | -126.53% | -220.61% | -421.4% | -$4.7M |
SINTX Technologies, Inc. vs. Competitors
-
Which has Higher Returns SINT or IVF?
INVO Fertility, Inc. has a net margin of -1701.44% compared to SINTX Technologies, Inc.'s net margin of -150.51%. SINTX Technologies, Inc.'s return on equity of -208.36% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About SINT or IVF?
SINTX Technologies, Inc. has a consensus price target of $12.25, signalling upside risk potential of 246.05%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 16375.97%. Given that INVO Fertility, Inc. has higher upside potential than SINTX Technologies, Inc., analysts believe INVO Fertility, Inc. is more attractive than SINTX Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies, Inc.2 0 0 IVFINVO Fertility, Inc.0 0 0 -
Is SINT or IVF More Risky?
SINTX Technologies, Inc. has a beta of 0.633, which suggesting that the stock is 36.717% less volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock SINT or IVF?
SINTX Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or IVF?
SINTX Technologies, Inc. quarterly revenues are $208K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. SINTX Technologies, Inc.'s net income of -$3.5M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, SINTX Technologies, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies, Inc. is 6.00x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies, Inc.6.00x -- $208K -$3.5M IVFINVO Fertility, Inc.0.02x -- $1.8M -$2.6M
-
Which has Higher Returns SINT or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -1701.44% compared to SINTX Technologies, Inc.'s net margin of -59.08%. SINTX Technologies, Inc.'s return on equity of -208.36% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About SINT or NMTC?
SINTX Technologies, Inc. has a consensus price target of $12.25, signalling upside risk potential of 246.05%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 190.55%. Given that SINTX Technologies, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe SINTX Technologies, Inc. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies, Inc.2 0 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is SINT or NMTC More Risky?
SINTX Technologies, Inc. has a beta of 0.633, which suggesting that the stock is 36.717% less volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock SINT or NMTC?
SINTX Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NMTC?
SINTX Technologies, Inc. quarterly revenues are $208K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. SINTX Technologies, Inc.'s net income of -$3.5M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, SINTX Technologies, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies, Inc. is 6.00x versus 2.54x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies, Inc.6.00x -- $208K -$3.5M NMTCNeuroOne Medical Technologies Corp.2.54x -- $2.7M -$1.6M
-
Which has Higher Returns SINT or NTRB?
Nutriband, Inc. has a net margin of -1701.44% compared to SINTX Technologies, Inc.'s net margin of -1118.87%. SINTX Technologies, Inc.'s return on equity of -208.36% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About SINT or NTRB?
SINTX Technologies, Inc. has a consensus price target of $12.25, signalling upside risk potential of 246.05%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 216.46%. Given that SINTX Technologies, Inc. has higher upside potential than Nutriband, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Nutriband, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies, Inc.2 0 0 NTRBNutriband, Inc.1 0 0 -
Is SINT or NTRB More Risky?
SINTX Technologies, Inc. has a beta of 0.633, which suggesting that the stock is 36.717% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock SINT or NTRB?
SINTX Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NTRB?
SINTX Technologies, Inc. quarterly revenues are $208K, which are smaller than Nutriband, Inc. quarterly revenues of $346.1K. SINTX Technologies, Inc.'s net income of -$3.5M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, SINTX Technologies, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies, Inc. is 6.00x versus 23.65x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies, Inc.6.00x -- $208K -$3.5M NTRBNutriband, Inc.23.65x -- $346.1K -$3.9M
-
Which has Higher Returns SINT or NVNO?
enVVeno Medical Corp. has a net margin of -1701.44% compared to SINTX Technologies, Inc.'s net margin of --. SINTX Technologies, Inc.'s return on equity of -208.36% beat enVVeno Medical Corp.'s return on equity of -57.7%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M NVNOenVVeno Medical Corp.-- -$0.23 $30.2M -
What do Analysts Say About SINT or NVNO?
SINTX Technologies, Inc. has a consensus price target of $12.25, signalling upside risk potential of 246.05%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3423.11%. Given that enVVeno Medical Corp. has higher upside potential than SINTX Technologies, Inc., analysts believe enVVeno Medical Corp. is more attractive than SINTX Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies, Inc.2 0 0 NVNOenVVeno Medical Corp.0 1 0 -
Is SINT or NVNO More Risky?
SINTX Technologies, Inc. has a beta of 0.633, which suggesting that the stock is 36.717% less volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.
-
Which is a Better Dividend Stock SINT or NVNO?
SINTX Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NVNO?
SINTX Technologies, Inc. quarterly revenues are $208K, which are larger than enVVeno Medical Corp. quarterly revenues of --. SINTX Technologies, Inc.'s net income of -$3.5M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, SINTX Technologies, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies, Inc. is 6.00x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies, Inc.6.00x -- $208K -$3.5M NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M
-
Which has Higher Returns SINT or XAIR?
Beyond Air, Inc. has a net margin of -1701.44% compared to SINTX Technologies, Inc.'s net margin of -454.24%. SINTX Technologies, Inc.'s return on equity of -208.36% beat Beyond Air, Inc.'s return on equity of -220.61%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M -
What do Analysts Say About SINT or XAIR?
SINTX Technologies, Inc. has a consensus price target of $12.25, signalling upside risk potential of 246.05%. On the other hand Beyond Air, Inc. has an analysts' consensus of $10.33 which suggests that it could grow by 1165.56%. Given that Beyond Air, Inc. has higher upside potential than SINTX Technologies, Inc., analysts believe Beyond Air, Inc. is more attractive than SINTX Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies, Inc.2 0 0 XAIRBeyond Air, Inc.2 1 0 -
Is SINT or XAIR More Risky?
SINTX Technologies, Inc. has a beta of 0.633, which suggesting that the stock is 36.717% less volatile than S&P 500. In comparison Beyond Air, Inc. has a beta of 0.304, suggesting its less volatile than the S&P 500 by 69.581%.
-
Which is a Better Dividend Stock SINT or XAIR?
SINTX Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies, Inc. pays -- of its earnings as a dividend. Beyond Air, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or XAIR?
SINTX Technologies, Inc. quarterly revenues are $208K, which are smaller than Beyond Air, Inc. quarterly revenues of $1.8M. SINTX Technologies, Inc.'s net income of -$3.5M is higher than Beyond Air, Inc.'s net income of -$8.3M. Notably, SINTX Technologies, Inc.'s price-to-earnings ratio is -- while Beyond Air, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies, Inc. is 6.00x versus 3.66x for Beyond Air, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies, Inc.6.00x -- $208K -$3.5M XAIRBeyond Air, Inc.3.66x -- $1.8M -$8.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
